ANTHEMAnthem Biosciences Limited
Pharma · Biotechnology · NSE · as of 2026-07-20 (delayed ~30 min in market hours)
₹791.55
▲ 1.87%Strong
Price & Volume
Loading chart…
Key Ratios
Market Cap (₹ cr)43,645.20
P/E74.71
P/B14.35
PEG0.59
ROE %21.71
ROCE %22.80
Debt / Equity0.02
EPS10.40
Revenue Growth %26.00
Profit Growth %125.80
Dividend Yield %0.26
Promoter Holding %84.18
FII Holding %10.76
DII Holding %—
Beta0.71
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
| Bollinger Squeeze | LONG | 77% | ₹791.55 | ₹764.40 | ₹845.84 | 2.00 |
BUYConviction 86%
Why buy
- • Revenue growth: 26.0% YoY
- • Profit growth: 125.8% YoY
- • ROE: 21.7%
- • RSI: 62
- • MACD: fresh bullish crossover
- • Price vs EMA21: above
- • Bollinger Squeeze signal (setup quality 77%)
Bull case
- • Revenue growth: 26.0% YoY
- • Profit growth: 125.8% YoY
- • ROE: 21.7%
- • RSI: 62
Bear case
- • Valuation vs sector: P/E 74.7 vs sector 38.6
- • Dividend yield: 0.26%
- • Supertrend: bearish
- • Trend strength (ADX): 15
Key risks
- • Valuation vs sector: P/E 74.7 vs sector 38.6
- • Dividend yield: 0.26%
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Entry (CMP)
₹791.55
Stop Loss
₹744.51
risk 5.9%
Target 1 (1.5R)
₹862.11
+8.9%
Target 2 (3R)
₹932.67
+17.8%
Support (20d)
₹742.50
Resistance (52w)
₹871.23
Risk : Reward
1 : 1.5 → 1 : 3
risking ₹47.04/share
ATR (volatility)
₹18.82
avg daily range
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹18.82). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.
Score Breakdown
Fundamental
85
Technical
75
Momentum
70
Risk (safety)
72